Takeover

Acquirers

Intas Pharmaceuticals Ltd.

Targets
1
Filings
2
Median premium
30%
First filing
Jan 14, 2025
Latest filing
Jan 28, 2025

Targets

CompanyTakeover scoreFilingsLatest
CHRSCoherus Oncology, Inc.42Jan 28, 2025

Deal filings

FiledCompanyFormPricePremium
Jan 28, 2025CHRSCoherus Oncology, Inc.DEFM14A$483.4030%
Jan 14, 2025CHRSCoherus Oncology, Inc.PREM14A$483.4027.5259075%